ATE474067T1 - Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen - Google Patents

Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen

Info

Publication number
ATE474067T1
ATE474067T1 AT07017086T AT07017086T ATE474067T1 AT E474067 T1 ATE474067 T1 AT E474067T1 AT 07017086 T AT07017086 T AT 07017086T AT 07017086 T AT07017086 T AT 07017086T AT E474067 T1 ATE474067 T1 AT E474067T1
Authority
AT
Austria
Prior art keywords
drug sensitivity
analyzing
channel genes
determining drug
girk channel
Prior art date
Application number
AT07017086T
Other languages
English (en)
Inventor
Kazutaka Ikeda
Masakazu Hayashida
Daisuke Nishizawa
Ichiro Sora
Original Assignee
Tokyo Metropolitan Org Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Metropolitan Org Med Res filed Critical Tokyo Metropolitan Org Med Res
Application granted granted Critical
Publication of ATE474067T1 publication Critical patent/ATE474067T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT07017086T 2006-08-31 2007-08-31 Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen ATE474067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006235352 2006-08-31
JP2007221298A JP5308644B2 (ja) 2006-08-31 2007-08-28 Ｇｉｒｋチャネル遺伝子解析による薬物感受性の評価方法

Publications (1)

Publication Number Publication Date
ATE474067T1 true ATE474067T1 (de) 2010-07-15

Family

ID=38824985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07017086T ATE474067T1 (de) 2006-08-31 2007-08-31 Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen

Country Status (5)

Country Link
US (1) US7858313B2 (de)
EP (1) EP1895016B1 (de)
JP (1) JP5308644B2 (de)
AT (1) ATE474067T1 (de)
DE (1) DE602007007697D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6053267B2 (ja) * 2010-09-03 2016-12-27 公益財団法人東京都医学総合研究所 アドレナリン受容体遺伝子解析による薬物感受性および疾患脆弱性の評価方法
EP3483288B1 (de) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalisiertes schmerzmanagement und anästhesie: präventive risikoidentifizierung
CN102381970B (zh) * 2011-12-08 2014-01-15 南京优科生物医药有限公司 一种制备氟比洛芬酯化合物的方法
JP6265743B2 (ja) * 2011-12-28 2018-01-24 公益財団法人東京都医学総合研究所 各種鎮痛関連遺伝子解析による薬物感受性の評価方法
CA2940422A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
US11618924B2 (en) 2017-01-20 2023-04-04 Children's Hospital Medical Center Methods and compositions relating to OPRM1 DNA methylation for personalized pain management
CN108962339A (zh) * 2018-06-11 2018-12-07 山东中医药大学附属医院 基因多态性与血脂水平的关联性对照方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003000258A (ja) * 2001-06-13 2003-01-07 Inst Of Physical & Chemical Res 薬物感受性の評価方法
WO2004053084A2 (en) * 2002-12-09 2004-06-24 The Mclean Hospital Corporation Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
US20050287574A1 (en) * 2004-06-23 2005-12-29 Medtronic, Inc. Genetic diagnostic method for SCD risk stratification
US8080371B2 (en) * 2006-03-01 2011-12-20 The Washington University Markers for addiction
US20080248470A1 (en) * 2007-04-04 2008-10-09 Sungkyunkwan University Foundation For Corporate Collaboration Genetic screening for predicting antidepressant drug response based on the monoamine transporter gene polymorphism combination

Also Published As

Publication number Publication date
EP1895016B1 (de) 2010-07-14
EP1895016A1 (de) 2008-03-05
DE602007007697D1 (de) 2010-08-26
JP5308644B2 (ja) 2013-10-09
US7858313B2 (en) 2010-12-28
JP2008079607A (ja) 2008-04-10
US20090092972A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
ATE474067T1 (de) Verfahren zur ermittlung von arzneimittelempfindlichkeit durch analyse von girk-kanal-genen
EP2181410A4 (de) Verfahren und system zum durchführen einer auf t-spline basierenden isogeometrischen analyse
EP2029009A4 (de) Eeg-analysesystem
DE602007003165D1 (de) Verfahren und Systeme zur Definition, Identifikation und Erfassung geometrischer Eigenschaften
EP2092515A4 (de) Verfahren zur auswahl interaktiver antwortmodi mitttels analyse von menschlicher stimmenerfassung
EP2002260A4 (de) Hochsensitives system und verfahren zur troponinanalyse
NO20083957L (no) DNA-konformasjon
EP3636776C0 (de) Verfahren zur analyse von sequenzinformation von nukleinsäuren unter berücksichtigung des gc biases, optional zur diagnose von nukleinsäureanomalien in foeten.
EP2217903A4 (de) Probeninjektionssystem
EP2317304A4 (de) Probenanalysevorrichtung
EP2079501A4 (de) Extravaskuläre systembelüftung
EP1954827A4 (de) Schnelle parallele nukleinsäureanalyse
BRPI0710123A2 (pt) Previsão de heterose e outros traços por análise de transcriptoma.
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
ATE438739T1 (de) Verfahren und zusammensetzungen zur analyse von ahasl-genen
EP3677905C0 (de) Integriertes biochipsystem für nukleinsäureanalyse
EP2115158A4 (de) Datenverarbeitung, analyseverfahren für genexpressionsdaten zur identifizierung endogener referenzgene
EP2250474A4 (de) Verfahren und system zur spektraldatenanalyse
WO2005073408A3 (en) Small segments of dna determine animal identity and source
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
EP2223213A4 (de) Mehrsprachensoftware-codeanalyse
WO2008065682A3 (en) Genetic susceptibility variants of type 2 diabetes mellitus
ATE555214T1 (de) Verfahren zur diagnose proliferativer erkrankungen durch detektion von genmethylierung
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties